Duravant to Acquire Pattyn, Provider of Packaging Automation Systems for Bulk and Industrial Applications
7.2.2025 15:00:00 CET | Business Wire | Press release
Automation solutions leader Duravant has signed a definitive agreement to acquire Pattyn.
Duravant LLC (“Duravant”), a global engineered equipment and automation solutions provider to the food processing, packaging and material handling sectors, announced today that it has entered into a definitive agreement to acquire the Pattyn Group BV (‘Pattyn”), a designer and manufacturer of automation systems specializing in B2B packaging. Pattyn is recognized as the premier leader for delivering comprehensive automation solutions and value-added services for bag-in-box packaging applications. Headquartered in Bruges, Belgium, Pattyn has over 70 years of expertise in machinery design and turnkey systems for counting, weighing, filling, and packing technologies for food, ingredients, and various non-food sectors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250207117623/en/
“We are extremely excited to partner with Pattyn,” said Mike Kachmer, Chairman and CEO of Duravant. “Pattyn has a rich history delivering high quality solutions to a global customer base in over 80 countries. Their impressive growth is attributed to their unwavering focus on customer satisfaction and building lasting relationships, which aligns perfectly with Duravant’s dedication to ensuring customer success.”
Pattyn operates out of six specialized manufacturing sites in Belgium, France and Spain and has sales and service divisions in North America and Asia. Founded by Jean Pattyn in 1952 and expanded through the vision of Paul Pattyn in 1976, the company grew from a local business to a worldwide supplier of packaging automation. Pattyn’s third generation owners and shareholders Stan Pattyn and Lynn Pattyn, alongside Pattyn COO Benjamin de Chilly, further led the company’s transformation with continuous innovation and development of new packaging technologies, digital offerings, and a service-minded approach from design to installation and complete aftermarket support.
“Pattyn has had a strong track record of solid performance, and we know that our potential to grow faster will happen alongside a strong partner,” said Stan Pattyn. “Through further investments in product development, operational excellence, and emerging market expansion, we will not only continue to thrive, but we will be empowered to better serve our customers and partners around the globe. Duravant is the perfect partner for the Pattyn Group and our employees.”
“We are thrilled to join forces with Duravant and collaborate with their family of world-class brands,” said Lynn Pattyn. “Duravant has a leading position across a wide array of end markets, from food & beverage to consumer goods, agriculture and industrial goods, to logistics and e-commerce. Pattyn’s opportunity to expand into new end markets with Duravant is core to our growth vision. But what’s most exciting is that Duravant’s customer-centric culture aligns perfectly with Pattyn’s commitment to delivering an excellent customer experience. We share that same DNA.”
Benjamin de Chilly adds, “Duravant is a true global organization with deep roots in Europe. They have a strong manufacturing footprint on the continent with renowned automation equipment brands such as Mespack, Votech, Marelec, Foodmate, Henneken, Multiscan, FMH Conveyors and Motion06. They recently invested in emerging markets Brazil, Mexico, China and Thailand where they established local sales, parts and service infrastructure to enhance their ability to serve customers in those regions.”
Pattyn represents a strategic acquisition for Duravant, expanding the company’s packaging machinery portfolio with innovative engineered solutions. Pattyn’s advanced automation technologies provide custom solutions through modular system designs while their equipment and consumables meet the highest food safety standards. Pattyn’s strong solution set for bakery applications further deepens Duravant’s relationships with customers in this sector.
The transaction, which remains subject to customary regulatory approvals, is expected to close in the second quarter of 2025. Following the close of the transaction, Pattyn will be a distinct Operating Company within Duravant’s Packaging Solutions Group. The current Pattyn Group management team will continue to oversee operations after the completion of the sale, and Pattyn’s 550 employees will join Duravant’s 3600 employees around the globe.
About Duravant
Headquartered in Downers Grove, IL, Duravant is a global engineered equipment company with manufacturing, sales and service facilities throughout North America, South America, Europe and Asia. Through their portfolio of operating companies, Duravant delivers trusted end-to-end automation solutions for customers and partners through engineering and integration expertise, project management and operational excellence. With worldwide sales distribution and support through the Duravant Lifecycle Services network, they provide immediate and lifetime aftermarket support to all the markets they serve in the protein processing, food sorting and handling, packaging, and material handling sectors. Duravant’s market-leading brands are synonymous with innovation, durability and reliability. For more information, visit www.duravant.com.
About Pattyn
Headquartered in Bruges, Belgium, Pattyn Group is a manufacturer and service provider of innovative and highly engineered packaging automation equipment specializing in modular solutions for counting, weighing, filling and bag-in-a-box applications. Since 1952, the company serves the B2B packaging segment and a diverse customer base that includes food and non-food producers in over 80 countries worldwide. Committed to fostering lifetime partnerships, Pattyn designs and delivers turnkey packaging lines with innovative modular designs that deliver custom solutions. The company provides aftermarket support with consumables, parts and comprehensive service programs. With 6 manufacturing sites in Belgium, France and Spain, and sales and service hubs in the United States and Asia, Pattyn partners with their customers to improve the efficiency, performance and quality of their industrial packaging needs. For more information, visit www.pattyn.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250207117623/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom